by Bill Pursche, McKinsey & Company, Inc.
The pharmaceutical industry is now in its second wave of consolidation. The first wave took place in the late 1980s,...
Creating Value from Horizontal Integration
The pharmaceutical industry is consolidating. Unaffordable overhead, redundant product lines, and excess sales and development capacity are creating the rationale for the new horizontal integration.
More from Business Strategy
More from In Vivo
• By
MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.
• By
In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.
• By
Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.